Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Ribback

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|June 15, 2021
YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in MiceXinjun Lu, Baogang Peng, Ge Chen, et al.
Hepatology (Baltimore, Md.)|February 15, 2023
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinomaCindy E Ament, Sara Steinmann, Katja Evert, et al.
BJU International|August 14, 2017
Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practiceJens Bedke, Johannes Heide, Silvia Ribback, et al.
Cell Death & Disease|January 20, 2018
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical modelMingjie Dong, Xianqiong Liu, Katja Evert, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 24, 2020
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse HepatocarcinogenesisHaichuan Wang, Jingxiao Wang, Shanshan Zhang, et al.
Oncotarget|April 1, 2015
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liverXiaolei Li, Junyan Tao, Antonio Cigliano, et al.
Medicina (Kaunas, Lithuania)|July 27, 2024
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27<sup>KIP1</sup> RegulationAntonio Cigliano, Maria M Simile, Gianpaolo Vidili, et al.
The American Journal of Pathology|January 30, 2018
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and HumansShanshan Zhang, Jingxiao Wang, Haichuan Wang, et al.
Oncotarget|September 15, 2017
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines <i>in vitro</i> and AKT-driven hepatocarcinogenesis in miceAntonio Cigliano, Chunmei Wang, Maria G Pilo, et al.
International Journal of Molecular Sciences|November 9, 2024
Knockout of the Carbohydrate Responsive Element Binding Protein Enhances Proliferation and Tumorigenesis in Renal Tubules of MiceKerrin Hansen, Kristin Peters, Christian K Burkert, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|June 15, 2021
YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in MiceXinjun Lu, Baogang Peng, Ge Chen, et al.
Hepatology (Baltimore, Md.)|February 15, 2023
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinomaCindy E Ament, Sara Steinmann, Katja Evert, et al.
BJU International|August 14, 2017
Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practiceJens Bedke, Johannes Heide, Silvia Ribback, et al.
Cell Death & Disease|January 20, 2018
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical modelMingjie Dong, Xianqiong Liu, Katja Evert, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 24, 2020
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse HepatocarcinogenesisHaichuan Wang, Jingxiao Wang, Shanshan Zhang, et al.
Oncotarget|April 1, 2015
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liverXiaolei Li, Junyan Tao, Antonio Cigliano, et al.
Medicina (Kaunas, Lithuania)|July 27, 2024
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27<sup>KIP1</sup> RegulationAntonio Cigliano, Maria M Simile, Gianpaolo Vidili, et al.
The American Journal of Pathology|January 30, 2018
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and HumansShanshan Zhang, Jingxiao Wang, Haichuan Wang, et al.
Oncotarget|September 15, 2017
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines <i>in vitro</i> and AKT-driven hepatocarcinogenesis in miceAntonio Cigliano, Chunmei Wang, Maria G Pilo, et al.
International Journal of Molecular Sciences|November 9, 2024
Knockout of the Carbohydrate Responsive Element Binding Protein Enhances Proliferation and Tumorigenesis in Renal Tubules of MiceKerrin Hansen, Kristin Peters, Christian K Burkert, et al.
Pageof 10